329 related articles for article (PubMed ID: 27108092)
21. Impact of universal pneumococcal vaccination on hospitalizations for pneumonia and meningitis in children in Montevideo, Uruguay.
Pírez MC; Algorta G; Cedrés A; Sobrero H; Varela A; Giachetto G; Montano A
Pediatr Infect Dis J; 2011 Aug; 30(8):669-74. PubMed ID: 21407145
[TBL] [Abstract][Full Text] [Related]
22. Direct and indirect effects of the 13-valent pneumococcal conjugate vaccine administered to infants and young children.
Esposito S; Principi N;
Future Microbiol; 2015; 10(10):1599-607. PubMed ID: 26439470
[TBL] [Abstract][Full Text] [Related]
23. Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults.
Bonten MJ; Huijts SM; Bolkenbaas M; Webber C; Patterson S; Gault S; van Werkhoven CH; van Deursen AM; Sanders EA; Verheij TJ; Patton M; McDonough A; Moradoghli-Haftvani A; Smith H; Mellelieu T; Pride MW; Crowther G; Schmoele-Thoma B; Scott DA; Jansen KU; Lobatto R; Oosterman B; Visser N; Caspers E; Smorenburg A; Emini EA; Gruber WC; Grobbee DE
N Engl J Med; 2015 Mar; 372(12):1114-25. PubMed ID: 25785969
[TBL] [Abstract][Full Text] [Related]
24. Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Hospitalization for Community-Acquired Pneumonia in Older US Adults: A Test-Negative Design.
McLaughlin JM; Jiang Q; Isturiz RE; Sings HL; Swerdlow DL; Gessner BD; Carrico RM; Peyrani P; Wiemken TL; Mattingly WA; Ramirez JA; Jodar L
Clin Infect Dis; 2018 Oct; 67(10):1498-1506. PubMed ID: 29790925
[TBL] [Abstract][Full Text] [Related]
25. Appropriateness of administrative data for vaccine impact evaluation: the case of pneumonia hospitalizations and pneumococcal vaccine in Brazil.
Sgambatti S; Minamisava R; Afonso ET; Toscano CM; Bierrenbach AL; Andrade AL
Epidemiol Infect; 2015 Jan; 143(2):334-42. PubMed ID: 24759601
[TBL] [Abstract][Full Text] [Related]
26. Changes in childhood pneumonia and infant mortality rates following introduction of the 13-valent pneumococcal conjugate vaccine in Nicaragua.
Becker-Dreps S; Amaya E; Liu L; Moreno G; Rocha J; Briceño R; Alemán J; Hudgens MG; Woods CW; Weber DJ
Pediatr Infect Dis J; 2014 Jun; 33(6):637-42. PubMed ID: 24445827
[TBL] [Abstract][Full Text] [Related]
27. Long-term Association of 13-Valent Pneumococcal Conjugate Vaccine Implementation With Rates of Community-Acquired Pneumonia in Children.
Ouldali N; Levy C; Minodier P; Morin L; Biscardi S; Aurel M; Dubos F; Dommergues MA; Mezgueldi E; Levieux K; Madhi F; Hees L; Craiu I; Gras Le Guen C; Launay E; Zenkhri F; Lorrot M; Gillet Y; Béchet S; Hau I; Martinot A; Varon E; Angoulvant F; Cohen R
JAMA Pediatr; 2019 Apr; 173(4):362-370. PubMed ID: 30715140
[TBL] [Abstract][Full Text] [Related]
28. Pneumococcal vaccines and the prevention of community-acquired pneumonia.
Esposito S; Principi N
Pulm Pharmacol Ther; 2015 Jun; 32():124-9. PubMed ID: 24607597
[TBL] [Abstract][Full Text] [Related]
29. The impact of pneumococcal conjugate vaccine on community-acquired pneumonia hospitalizations in children with comorbidity.
Sterky E; Bennet R; Lindstrand A; Eriksson M; Nilsson A
Eur J Pediatr; 2017 Mar; 176(3):337-342. PubMed ID: 28070670
[TBL] [Abstract][Full Text] [Related]
30. The effectiveness of the polysaccharide pneumococcal vaccine for the prevention of hospitalizations due to Streptococcus pneumoniae community-acquired pneumonia in the elderly differs between the sexes: results from the Community-Acquired Pneumonia Organization (CAPO) international cohort study.
Wiemken TL; Carrico RM; Klein SL; Jonsson CB; Peyrani P; Kelley RR; Aliberti S; Blasi F; Fernandez-Gonzalez R; Lopardo G; Ramirez JA;
Vaccine; 2014 Apr; 32(19):2198-203. PubMed ID: 24613522
[TBL] [Abstract][Full Text] [Related]
31. Effectiveness of the 13-valent pneumococcal conjugate vaccine against adult pneumonia in Italy: a case-control study in a 2-year prospective cohort.
Prato R; Fortunato F; Cappelli MG; Chironna M; Martinelli D
BMJ Open; 2018 Mar; 8(3):e019034. PubMed ID: 29581200
[TBL] [Abstract][Full Text] [Related]
32. Role of Streptococcus pneumoniae in hospitalization for acute community-acquired pneumonia associated with culture-confirmed Mycobacterium tuberculosis in children: a pneumococcal conjugate vaccine probe study.
Moore DP; Klugman KP; Madhi SA
Pediatr Infect Dis J; 2010 Dec; 29(12):1099-04. PubMed ID: 21155174
[TBL] [Abstract][Full Text] [Related]
33. A population-based analysis to determine the impact of the 13-valent pneumococcal conjugate vaccine on community-acquired pneumonia in British Columbia, Canada.
Vadlamudi NK; Patrick DM; Rose C; Sadatsafavi M; Hoang L; Marra F
Vaccine; 2022 Feb; 40(7):1047-1053. PubMed ID: 35012778
[TBL] [Abstract][Full Text] [Related]
34. Empyema hospitalizations increased in US children despite pneumococcal conjugate vaccine.
Li ST; Tancredi DJ
Pediatrics; 2010 Jan; 125(1):26-33. PubMed ID: 19948570
[TBL] [Abstract][Full Text] [Related]
35. The potential role of pneumococcal conjugate vaccine in reducing acute respiratory inflammation in community-acquired pneumococcal pneumonia.
Shen CF; Wang SM; Chi H; Huang YC; Huang LM; Huang YC; Lin HC; Ho YH; Hsiung CA; Liu CC;
J Biomed Sci; 2020 Aug; 27(1):88. PubMed ID: 32814590
[TBL] [Abstract][Full Text] [Related]
36. Pneumococcal vaccine effect on hospitalisation rates of pneumonia in children: A meta-analysis.
Zhu X; Li X
Int J Clin Pract; 2021 Nov; 75(11):e14739. PubMed ID: 34388857
[TBL] [Abstract][Full Text] [Related]
37. Impact of pneumococcal conjugate vaccination of infants on pneumonia and influenza hospitalization and mortality in all age groups in the United States.
Simonsen L; Taylor RJ; Young-Xu Y; Haber M; May L; Klugman KP
mBio; 2011 Jan; 2(1):e00309-10. PubMed ID: 21264063
[TBL] [Abstract][Full Text] [Related]
38. Pneumococcal conjugate vaccine use in adults.
Isturiz RE; Schmoele-Thoma B; Scott DA; Jodar L; Webber C; Sings HL; Paradiso P
Expert Rev Vaccines; 2016; 15(3):279-93. PubMed ID: 26651847
[TBL] [Abstract][Full Text] [Related]
39. Changes in hospitalizations for pneumonia after universal vaccination with pneumococcal conjugate vaccines 7/13 valent and haemophilus influenzae type b conjugate vaccine in a Pediatric Referral Hospital in Uruguay.
Pírez MC; Algorta G; Chamorro F; Romero C; Varela A; Cedres A; Giachetto G; Montano A
Pediatr Infect Dis J; 2014 Jul; 33(7):753-9. PubMed ID: 24492286
[TBL] [Abstract][Full Text] [Related]
40. Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against community-acquired pneumonia in the general population aged ≥ 60 years: 3 years of follow-up in the CAPAMIS study.
Ochoa-Gondar O; Vila-Corcoles A; Rodriguez-Blanco T; Gomez-Bertomeu F; Figuerola-Massana E; Raga-Luria X; Hospital-Guardiola I
Clin Infect Dis; 2014 Apr; 58(7):909-17. PubMed ID: 24532544
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
